• Explore /
  • Poster
  • / Use of circulating tumor DNA (ctDNA) for early assessment of treatment response in patients with advanced colorectal cancer (aCRC): A real-world (RW) analysis.

Use of circulating tumor DNA (ctDNA) for early assessment of treatment response in patients with advanced colorectal cancer (aCRC): A real-world (RW) analysis.

Abstract Poster

Authors

Pashtoon Kasi

Pashtoon Murtaza Kasi

Weill Cornell Medicine, New York City, NY;

Pashtoon Murtaza Kasi , Caroline Weipert , Tim Nguyen , Jiemin Liao , Nicole Zhang , Shaun Forbes , Sean Gordon , Benjamin R. Tan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 246)

DOI

10.1200/JCO.2023.41.4_suppl.246

Abstract #

246

Poster Bd #

N8

Abstract Disclosures

Similar Posters

First Author: Natalie I Vokes

First Author: Seth Andrew Wander

First Author: Tao Jiang

First Author: Gabriel Berlingieri Polho